ACE2 and infection: Strikingly, utilization of all ACE2 orthologues was increased by 3- to 57-fold and the mutant T403R RaTG13 S was capable of using all ACE2 orthologs at least as efficiently as the SARS-CoV-2 Hu-1 S for infection (Fig. 3a).